Precision Lipid Management in the Era of Biotechnology and Artificial Intelligence: From Gene Editing to Smart Drug Delivery.
This narrative review critically evaluates emerging biotechnology- and artificial intelligence (AI)enhanced approaches for hyperlipidemia, emphasizing translational maturity, clinical applicability, and regulatory implications.
Esra Palabıyık
· Therapeutic Innovation and... · 0 citations